0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Non-opioid Pain Med - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-5J14180
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Non opioid Pain Med Market Research Report 2023
BUY CHAPTERS

Non-opioid Pain Med - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-5J14180
Report
April 2024
Pages:164
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-opioid Pain Med - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Non-opioid Pain Med - Market

Non-opioid Pain Med - Market

The global market for Non-opioid Pain Med was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-opioid Pain Med, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-opioid Pain Med by region & country, by Type, and by Application.
The Non-opioid Pain Med market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-opioid Pain Med.
Market Segmentation

Scope of Non-opioid Pain Med - Market Report

Report Metric Details
Report Name Non-opioid Pain Med - Market
CAGR 5%
Segment by Type:
  • Diclofenac Sodium
  • Acetaminophen
  • Indomethacin
  • Ibuprofen
  • Aspirin
  • Others
Segment by Application
  • Mild Pain
  • Moderate Pain
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company WEX Pharmaceuticals Inc., BASF, Xinhua Pharm, Johnson & Johnson(McNeil Consumer Healthcare), Granules Biocause, Novacyl, Pfizer, Hisoar, Anant Pharmaceuticals Pvt. Ltd., Strides Shasun, SI Group, Elam Pharma, AdvaCare Pharma, IOL, Jingye Group, NS Chemicals, Hunan Zhongnan Pharmaceutical, Nanjing Pharmaceutical Factory, Huayin Jinqiancheng Pharmaceutical Co., Ltd., Mallinckrodt Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Non-opioid Pain Med manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Non-opioid Pain Med in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Non-opioid Pain Med in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Non-opioid Pain Med - Market report?

Ans: The main players in the Non-opioid Pain Med - Market are WEX Pharmaceuticals Inc., BASF, Xinhua Pharm, Johnson & Johnson(McNeil Consumer Healthcare), Granules Biocause, Novacyl, Pfizer, Hisoar, Anant Pharmaceuticals Pvt. Ltd., Strides Shasun, SI Group, Elam Pharma, AdvaCare Pharma, IOL, Jingye Group, NS Chemicals, Hunan Zhongnan Pharmaceutical, Nanjing Pharmaceutical Factory, Huayin Jinqiancheng Pharmaceutical Co., Ltd., Mallinckrodt Pharmaceuticals

What are the Application segmentation covered in the Non-opioid Pain Med - Market report?

Ans: The Applications covered in the Non-opioid Pain Med - Market report are Mild Pain, Moderate Pain

What are the Type segmentation covered in the Non-opioid Pain Med - Market report?

Ans: The Types covered in the Non-opioid Pain Med - Market report are Diclofenac Sodium, Acetaminophen, Indomethacin, Ibuprofen, Aspirin, Others

1 Market Overview
1.1 Non-opioid Pain Med Product Introduction
1.2 Global Non-opioid Pain Med Market Size Forecast
1.2.1 Global Non-opioid Pain Med Sales Value (2019-2030)
1.2.2 Global Non-opioid Pain Med Sales Volume (2019-2030)
1.2.3 Global Non-opioid Pain Med Sales Price (2019-2030)
1.3 Non-opioid Pain Med Market Trends & Drivers
1.3.1 Non-opioid Pain Med Industry Trends
1.3.2 Non-opioid Pain Med Market Drivers & Opportunity
1.3.3 Non-opioid Pain Med Market Challenges
1.3.4 Non-opioid Pain Med Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-opioid Pain Med Players Revenue Ranking (2023)
2.2 Global Non-opioid Pain Med Revenue by Company (2019-2024)
2.3 Global Non-opioid Pain Med Players Sales Volume Ranking (2023)
2.4 Global Non-opioid Pain Med Sales Volume by Company Players (2019-2024)
2.5 Global Non-opioid Pain Med Average Price by Company (2019-2024)
2.6 Key Manufacturers Non-opioid Pain Med Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Non-opioid Pain Med Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Non-opioid Pain Med
2.9 Non-opioid Pain Med Market Competitive Analysis
2.9.1 Non-opioid Pain Med Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-opioid Pain Med Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Pain Med as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Diclofenac Sodium
3.1.2 Acetaminophen
3.1.3 Indomethacin
3.1.4 Ibuprofen
3.1.5 Aspirin
3.1.6 Others
3.2 Global Non-opioid Pain Med Sales Value by Type
3.2.1 Global Non-opioid Pain Med Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Non-opioid Pain Med Sales Value, by Type (2019-2030)
3.2.3 Global Non-opioid Pain Med Sales Value, by Type (%) (2019-2030)
3.3 Global Non-opioid Pain Med Sales Volume by Type
3.3.1 Global Non-opioid Pain Med Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Non-opioid Pain Med Sales Volume, by Type (2019-2030)
3.3.3 Global Non-opioid Pain Med Sales Volume, by Type (%) (2019-2030)
3.4 Global Non-opioid Pain Med Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Mild Pain
4.1.2 Moderate Pain
4.2 Global Non-opioid Pain Med Sales Value by Application
4.2.1 Global Non-opioid Pain Med Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Non-opioid Pain Med Sales Value, by Application (2019-2030)
4.2.3 Global Non-opioid Pain Med Sales Value, by Application (%) (2019-2030)
4.3 Global Non-opioid Pain Med Sales Volume by Application
4.3.1 Global Non-opioid Pain Med Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Non-opioid Pain Med Sales Volume, by Application (2019-2030)
4.3.3 Global Non-opioid Pain Med Sales Volume, by Application (%) (2019-2030)
4.4 Global Non-opioid Pain Med Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Non-opioid Pain Med Sales Value by Region
5.1.1 Global Non-opioid Pain Med Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Non-opioid Pain Med Sales Value by Region (2019-2024)
5.1.3 Global Non-opioid Pain Med Sales Value by Region (2025-2030)
5.1.4 Global Non-opioid Pain Med Sales Value by Region (%), (2019-2030)
5.2 Global Non-opioid Pain Med Sales Volume by Region
5.2.1 Global Non-opioid Pain Med Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Non-opioid Pain Med Sales Volume by Region (2019-2024)
5.2.3 Global Non-opioid Pain Med Sales Volume by Region (2025-2030)
5.2.4 Global Non-opioid Pain Med Sales Volume by Region (%), (2019-2030)
5.3 Global Non-opioid Pain Med Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Non-opioid Pain Med Sales Value, 2019-2030
5.4.2 North America Non-opioid Pain Med Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Non-opioid Pain Med Sales Value, 2019-2030
5.5.2 Europe Non-opioid Pain Med Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Non-opioid Pain Med Sales Value, 2019-2030
5.6.2 Asia Pacific Non-opioid Pain Med Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Non-opioid Pain Med Sales Value, 2019-2030
5.7.2 South America Non-opioid Pain Med Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-opioid Pain Med Sales Value, 2019-2030
5.8.2 Middle East & Africa Non-opioid Pain Med Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-opioid Pain Med Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Non-opioid Pain Med Sales Value
6.2.1 Key Countries/Regions Non-opioid Pain Med Sales Value, 2019-2030
6.2.2 Key Countries/Regions Non-opioid Pain Med Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Non-opioid Pain Med Sales Value, 2019-2030
6.3.2 United States Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Non-opioid Pain Med Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Non-opioid Pain Med Sales Value, 2019-2030
6.4.2 Europe Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Non-opioid Pain Med Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Non-opioid Pain Med Sales Value, 2019-2030
6.5.2 China Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
6.5.3 China Non-opioid Pain Med Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Non-opioid Pain Med Sales Value, 2019-2030
6.6.2 Japan Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Non-opioid Pain Med Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Non-opioid Pain Med Sales Value, 2019-2030
6.7.2 South Korea Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Non-opioid Pain Med Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Non-opioid Pain Med Sales Value, 2019-2030
6.8.2 Southeast Asia Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Non-opioid Pain Med Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Non-opioid Pain Med Sales Value, 2019-2030
6.9.2 India Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
6.9.3 India Non-opioid Pain Med Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 WEX Pharmaceuticals Inc.
7.1.1 WEX Pharmaceuticals Inc. Company Information
7.1.2 WEX Pharmaceuticals Inc. Introduction and Business Overview
7.1.3 WEX Pharmaceuticals Inc. Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.1.4 WEX Pharmaceuticals Inc. Non-opioid Pain Med Product Offerings
7.1.5 WEX Pharmaceuticals Inc. Recent Development
7.2 BASF
7.2.1 BASF Company Information
7.2.2 BASF Introduction and Business Overview
7.2.3 BASF Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.2.4 BASF Non-opioid Pain Med Product Offerings
7.2.5 BASF Recent Development
7.3 Xinhua Pharm
7.3.1 Xinhua Pharm Company Information
7.3.2 Xinhua Pharm Introduction and Business Overview
7.3.3 Xinhua Pharm Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Xinhua Pharm Non-opioid Pain Med Product Offerings
7.3.5 Xinhua Pharm Recent Development
7.4 Johnson & Johnson(McNeil Consumer Healthcare)
7.4.1 Johnson & Johnson(McNeil Consumer Healthcare) Company Information
7.4.2 Johnson & Johnson(McNeil Consumer Healthcare) Introduction and Business Overview
7.4.3 Johnson & Johnson(McNeil Consumer Healthcare) Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Johnson & Johnson(McNeil Consumer Healthcare) Non-opioid Pain Med Product Offerings
7.4.5 Johnson & Johnson(McNeil Consumer Healthcare) Recent Development
7.5 Granules Biocause
7.5.1 Granules Biocause Company Information
7.5.2 Granules Biocause Introduction and Business Overview
7.5.3 Granules Biocause Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Granules Biocause Non-opioid Pain Med Product Offerings
7.5.5 Granules Biocause Recent Development
7.6 Novacyl
7.6.1 Novacyl Company Information
7.6.2 Novacyl Introduction and Business Overview
7.6.3 Novacyl Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Novacyl Non-opioid Pain Med Product Offerings
7.6.5 Novacyl Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Information
7.7.2 Pfizer Introduction and Business Overview
7.7.3 Pfizer Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Pfizer Non-opioid Pain Med Product Offerings
7.7.5 Pfizer Recent Development
7.8 Hisoar
7.8.1 Hisoar Company Information
7.8.2 Hisoar Introduction and Business Overview
7.8.3 Hisoar Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Hisoar Non-opioid Pain Med Product Offerings
7.8.5 Hisoar Recent Development
7.9 Anant Pharmaceuticals Pvt. Ltd.
7.9.1 Anant Pharmaceuticals Pvt. Ltd. Company Information
7.9.2 Anant Pharmaceuticals Pvt. Ltd. Introduction and Business Overview
7.9.3 Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Product Offerings
7.9.5 Anant Pharmaceuticals Pvt. Ltd. Recent Development
7.10 Strides Shasun
7.10.1 Strides Shasun Company Information
7.10.2 Strides Shasun Introduction and Business Overview
7.10.3 Strides Shasun Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Strides Shasun Non-opioid Pain Med Product Offerings
7.10.5 Strides Shasun Recent Development
7.11 SI Group
7.11.1 SI Group Company Information
7.11.2 SI Group Introduction and Business Overview
7.11.3 SI Group Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.11.4 SI Group Non-opioid Pain Med Product Offerings
7.11.5 SI Group Recent Development
7.12 Elam Pharma
7.12.1 Elam Pharma Company Information
7.12.2 Elam Pharma Introduction and Business Overview
7.12.3 Elam Pharma Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Elam Pharma Non-opioid Pain Med Product Offerings
7.12.5 Elam Pharma Recent Development
7.13 AdvaCare Pharma
7.13.1 AdvaCare Pharma Company Information
7.13.2 AdvaCare Pharma Introduction and Business Overview
7.13.3 AdvaCare Pharma Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.13.4 AdvaCare Pharma Non-opioid Pain Med Product Offerings
7.13.5 AdvaCare Pharma Recent Development
7.14 IOL
7.14.1 IOL Company Information
7.14.2 IOL Introduction and Business Overview
7.14.3 IOL Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.14.4 IOL Non-opioid Pain Med Product Offerings
7.14.5 IOL Recent Development
7.15 Jingye Group
7.15.1 Jingye Group Company Information
7.15.2 Jingye Group Introduction and Business Overview
7.15.3 Jingye Group Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Jingye Group Non-opioid Pain Med Product Offerings
7.15.5 Jingye Group Recent Development
7.16 NS Chemicals
7.16.1 NS Chemicals Company Information
7.16.2 NS Chemicals Introduction and Business Overview
7.16.3 NS Chemicals Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.16.4 NS Chemicals Non-opioid Pain Med Product Offerings
7.16.5 NS Chemicals Recent Development
7.17 Hunan Zhongnan Pharmaceutical
7.17.1 Hunan Zhongnan Pharmaceutical Company Information
7.17.2 Hunan Zhongnan Pharmaceutical Introduction and Business Overview
7.17.3 Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Product Offerings
7.17.5 Hunan Zhongnan Pharmaceutical Recent Development
7.18 Nanjing Pharmaceutical Factory
7.18.1 Nanjing Pharmaceutical Factory Company Information
7.18.2 Nanjing Pharmaceutical Factory Introduction and Business Overview
7.18.3 Nanjing Pharmaceutical Factory Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Nanjing Pharmaceutical Factory Non-opioid Pain Med Product Offerings
7.18.5 Nanjing Pharmaceutical Factory Recent Development
7.19 Huayin Jinqiancheng Pharmaceutical Co., Ltd.
7.19.1 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Company Information
7.19.2 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Introduction and Business Overview
7.19.3 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Product Offerings
7.19.5 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Recent Development
7.20 Mallinckrodt Pharmaceuticals
7.20.1 Mallinckrodt Pharmaceuticals Company Information
7.20.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview
7.20.3 Mallinckrodt Pharmaceuticals Non-opioid Pain Med Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Mallinckrodt Pharmaceuticals Non-opioid Pain Med Product Offerings
7.20.5 Mallinckrodt Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Non-opioid Pain Med Industrial Chain
8.2 Non-opioid Pain Med Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-opioid Pain Med Sales Model
8.5.2 Sales Channel
8.5.3 Non-opioid Pain Med Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Non-opioid Pain Med Market Trends
    Table 2. Non-opioid Pain Med Market Drivers & Opportunity
    Table 3. Non-opioid Pain Med Market Challenges
    Table 4. Non-opioid Pain Med Market Restraints
    Table 5. Global Non-opioid Pain Med Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Non-opioid Pain Med Revenue Market Share by Company (2019-2024)
    Table 7. Global Non-opioid Pain Med Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Non-opioid Pain Med Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Non-opioid Pain Med Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Non-opioid Pain Med Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Non-opioid Pain Med Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Non-opioid Pain Med
    Table 13. Global Non-opioid Pain Med Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Pain Med as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Non-opioid Pain Med Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Non-opioid Pain Med Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Non-opioid Pain Med Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Non-opioid Pain Med Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Non-opioid Pain Med Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Non-opioid Pain Med Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Non-opioid Pain Med Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Non-opioid Pain Med Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Non-opioid Pain Med Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Non-opioid Pain Med Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Non-opioid Pain Med Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Non-opioid Pain Med Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Non-opioid Pain Med Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Non-opioid Pain Med Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Non-opioid Pain Med Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Non-opioid Pain Med Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Non-opioid Pain Med Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Non-opioid Pain Med Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Non-opioid Pain Med Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Non-opioid Pain Med Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Non-opioid Pain Med Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Non-opioid Pain Med Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Non-opioid Pain Med Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Non-opioid Pain Med Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Non-opioid Pain Med Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Non-opioid Pain Med Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Non-opioid Pain Med Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Non-opioid Pain Med Sales Value by Region (2019-2024) & (%)
    Table 44. Global Non-opioid Pain Med Sales Value by Region (2025-2030) & (%)
    Table 45. Global Non-opioid Pain Med Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Non-opioid Pain Med Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Non-opioid Pain Med Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Non-opioid Pain Med Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Non-opioid Pain Med Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Non-opioid Pain Med Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Non-opioid Pain Med Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Non-opioid Pain Med Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Non-opioid Pain Med Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Non-opioid Pain Med Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Non-opioid Pain Med Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Non-opioid Pain Med Sales Volume, (2025-2030) & (K Units)
    Table 57. WEX Pharmaceuticals Inc. Company Information
    Table 58. WEX Pharmaceuticals Inc. Introduction and Business Overview
    Table 59. WEX Pharmaceuticals Inc. Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. WEX Pharmaceuticals Inc. Non-opioid Pain Med Product Offerings
    Table 61. WEX Pharmaceuticals Inc. Recent Development
    Table 62. BASF Company Information
    Table 63. BASF Introduction and Business Overview
    Table 64. BASF Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. BASF Non-opioid Pain Med Product Offerings
    Table 66. BASF Recent Development
    Table 67. Xinhua Pharm Company Information
    Table 68. Xinhua Pharm Introduction and Business Overview
    Table 69. Xinhua Pharm Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Xinhua Pharm Non-opioid Pain Med Product Offerings
    Table 71. Xinhua Pharm Recent Development
    Table 72. Johnson & Johnson(McNeil Consumer Healthcare) Company Information
    Table 73. Johnson & Johnson(McNeil Consumer Healthcare) Introduction and Business Overview
    Table 74. Johnson & Johnson(McNeil Consumer Healthcare) Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Johnson & Johnson(McNeil Consumer Healthcare) Non-opioid Pain Med Product Offerings
    Table 76. Johnson & Johnson(McNeil Consumer Healthcare) Recent Development
    Table 77. Granules Biocause Company Information
    Table 78. Granules Biocause Introduction and Business Overview
    Table 79. Granules Biocause Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Granules Biocause Non-opioid Pain Med Product Offerings
    Table 81. Granules Biocause Recent Development
    Table 82. Novacyl Company Information
    Table 83. Novacyl Introduction and Business Overview
    Table 84. Novacyl Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Novacyl Non-opioid Pain Med Product Offerings
    Table 86. Novacyl Recent Development
    Table 87. Pfizer Company Information
    Table 88. Pfizer Introduction and Business Overview
    Table 89. Pfizer Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Pfizer Non-opioid Pain Med Product Offerings
    Table 91. Pfizer Recent Development
    Table 92. Hisoar Company Information
    Table 93. Hisoar Introduction and Business Overview
    Table 94. Hisoar Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Hisoar Non-opioid Pain Med Product Offerings
    Table 96. Hisoar Recent Development
    Table 97. Anant Pharmaceuticals Pvt. Ltd. Company Information
    Table 98. Anant Pharmaceuticals Pvt. Ltd. Introduction and Business Overview
    Table 99. Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Product Offerings
    Table 101. Anant Pharmaceuticals Pvt. Ltd. Recent Development
    Table 102. Strides Shasun Company Information
    Table 103. Strides Shasun Introduction and Business Overview
    Table 104. Strides Shasun Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Strides Shasun Non-opioid Pain Med Product Offerings
    Table 106. Strides Shasun Recent Development
    Table 107. SI Group Company Information
    Table 108. SI Group Introduction and Business Overview
    Table 109. SI Group Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. SI Group Non-opioid Pain Med Product Offerings
    Table 111. SI Group Recent Development
    Table 112. Elam Pharma Company Information
    Table 113. Elam Pharma Introduction and Business Overview
    Table 114. Elam Pharma Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Elam Pharma Non-opioid Pain Med Product Offerings
    Table 116. Elam Pharma Recent Development
    Table 117. AdvaCare Pharma Company Information
    Table 118. AdvaCare Pharma Introduction and Business Overview
    Table 119. AdvaCare Pharma Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. AdvaCare Pharma Non-opioid Pain Med Product Offerings
    Table 121. AdvaCare Pharma Recent Development
    Table 122. IOL Company Information
    Table 123. IOL Introduction and Business Overview
    Table 124. IOL Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. IOL Non-opioid Pain Med Product Offerings
    Table 126. IOL Recent Development
    Table 127. Jingye Group Company Information
    Table 128. Jingye Group Introduction and Business Overview
    Table 129. Jingye Group Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Jingye Group Non-opioid Pain Med Product Offerings
    Table 131. Jingye Group Recent Development
    Table 132. NS Chemicals Company Information
    Table 133. NS Chemicals Introduction and Business Overview
    Table 134. NS Chemicals Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. NS Chemicals Non-opioid Pain Med Product Offerings
    Table 136. NS Chemicals Recent Development
    Table 137. Hunan Zhongnan Pharmaceutical Company Information
    Table 138. Hunan Zhongnan Pharmaceutical Introduction and Business Overview
    Table 139. Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Product Offerings
    Table 141. Hunan Zhongnan Pharmaceutical Recent Development
    Table 142. Nanjing Pharmaceutical Factory Company Information
    Table 143. Nanjing Pharmaceutical Factory Introduction and Business Overview
    Table 144. Nanjing Pharmaceutical Factory Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Nanjing Pharmaceutical Factory Non-opioid Pain Med Product Offerings
    Table 146. Nanjing Pharmaceutical Factory Recent Development
    Table 147. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Company Information
    Table 148. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 149. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Product Offerings
    Table 151. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Recent Development
    Table 152. Mallinckrodt Pharmaceuticals Company Information
    Table 153. Mallinckrodt Pharmaceuticals Introduction and Business Overview
    Table 154. Mallinckrodt Pharmaceuticals Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Mallinckrodt Pharmaceuticals Non-opioid Pain Med Product Offerings
    Table 156. Mallinckrodt Pharmaceuticals Recent Development
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Non-opioid Pain Med Downstream Customers
    Table 160. Non-opioid Pain Med Distributors List
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Non-opioid Pain Med Product Picture
    Figure 2. Global Non-opioid Pain Med Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Non-opioid Pain Med Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Non-opioid Pain Med Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Non-opioid Pain Med Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Non-opioid Pain Med Report Years Considered
    Figure 7. Global Non-opioid Pain Med Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Non-opioid Pain Med Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-opioid Pain Med Revenue in 2023
    Figure 10. Non-opioid Pain Med Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Diclofenac Sodium Picture
    Figure 12. Acetaminophen Picture
    Figure 13. Indomethacin Picture
    Figure 14. Ibuprofen Picture
    Figure 15. Aspirin Picture
    Figure 16. Others Picture
    Figure 17. Global Non-opioid Pain Med Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Non-opioid Pain Med Sales Value Market Share by Type, 2023 & 2030
    Figure 19. Global Non-opioid Pain Med Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 20. Global Non-opioid Pain Med Sales Volume Market Share by Type, 2023 & 2030
    Figure 21. Global Non-opioid Pain Med Price by Type (2019-2030) & (US$/Unit)
    Figure 22. Product Picture of Mild Pain
    Figure 23. Product Picture of Moderate Pain
    Figure 24. Global Non-opioid Pain Med Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Non-opioid Pain Med Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Non-opioid Pain Med Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Non-opioid Pain Med Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Non-opioid Pain Med Price by Application (2019-2030) & (US$/Unit)
    Figure 29. North America Non-opioid Pain Med Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Non-opioid Pain Med Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Non-opioid Pain Med Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Non-opioid Pain Med Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Non-opioid Pain Med Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Non-opioid Pain Med Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Non-opioid Pain Med Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Non-opioid Pain Med Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Non-opioid Pain Med Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Non-opioid Pain Med Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Non-opioid Pain Med Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Non-opioid Pain Med Sales Volume (%), (2019-2030)
    Figure 41. United States Non-opioid Pain Med Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Non-opioid Pain Med Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Non-opioid Pain Med Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Non-opioid Pain Med Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Non-opioid Pain Med Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Non-opioid Pain Med Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Non-opioid Pain Med Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Non-opioid Pain Med Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Non-opioid Pain Med Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Non-opioid Pain Med Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Non-opioid Pain Med Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Non-opioid Pain Med Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Non-opioid Pain Med Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Non-opioid Pain Med Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Non-opioid Pain Med Sales Value by Application (%), 2023 VS 2030
    Figure 62. Non-opioid Pain Med Industrial Chain
    Figure 63. Non-opioid Pain Med Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Atopic Dermatitis Medication Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6T12992
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Travel Medication Cooler Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6T13046
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Cancer Therapeutics and Supportive Care Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36P13126
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Imatinib Mesylate Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2G7707
Fri May 17 00:00:00 UTC 2024

Add to Cart